Biotest AG (OTCPK:BIESF)
$ 30.48 0 (0%) Market Cap: 1.46 Bil Enterprise Value: 1.99 Bil PE Ratio: 8.54 PB Ratio: 3.06 GF Score: 55/100

Nine Months 2019 Biotest AG Earnings Call Transcript

Nov 14, 2019 / 09:00AM GMT
Release Date Price: $24.77
Operator

Good morning, ladies and gentlemen. Welcome to the Biotest AG conference call. (Operator Instructions)

Let me now turn the floor over to Monika Buttkereit, Head of Investor Relations.

Monika Buttkereit
Biotest Aktiengesellschaft - Head of IR

Good morning, everyone. Welcome to the Biotest 9 Months Results Call. I'm here with Michael Ramroth, the CEO of Biotech AG, who will -- to whom I will hand over now.

Michael Ramroth
Biotest Aktiengesellschaft - Chairman of the Management Board, CEO & CFO

Thank you very much. And good morning to everybody. And thank you very much that you have decided to listening into Biotest's call this morning.

We know that a lot of other companies are also reporting numbers today. So we are really happy and glad that you made it and are listening to.

What we have to tell you, and what we are going to tell you are, of course, the numbers of the first 9 months of 2019. We will give you an update on the status of our development projects, keyword here is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot